Travere Therapeutics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US89422G1076
USD
27.75
-0.01 (-0.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
114.83
59.08
200.81
42.85
302.11
211.21
Shareholder's Funds
114.83
59.08
200.81
42.85
302.11
211.21
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
317.60
384.39
382.17
379.98
230.49
215.70
Secured Loans
317.60
384.39
382.17
379.98
230.49
215.70
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
18.73
23.99
32.93
112.03
123.85
88.23
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
330.46
334.30
410.19
487.57
350.43
303.57
Current Liabilities
Trade Payables
24.80
23.53
41.67
17.29
15.14
12.13
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
159.90
200.75
177.91
142.16
124.09
92.66
Total Liabilities
605.19
594.12
788.91
672.59
776.63
607.44
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
24.70
28.39
32.98
35.24
37.35
39.03
Less: Accumulated Depreciation
10.10
8.76
7.44
5.20
3.05
3.94
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
14.60
19.63
25.54
30.05
34.30
35.09
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
39.16
53.82
42.16
11.06
11.07
7.81
Total Non-Current Assets
167.63
177.42
172.14
186.15
193.81
197.03
Current Assets Loans & Advances
Current Investments
229.76
312.17
508.68
388.56
387.13
276.82
Inventories
5.88
6.20
9.41
6.92
7.31
7.61
Sundry Debtors
80.13
27.12
21.18
16.65
15.91
15.93
Cash and Bank
93.03
58.53
58.18
61.69
165.75
84.77
Other Current Assets
410.11
406.32
597.44
473.81
576.36
402.26
Short Term Loans and Advances
1.30
2.30
0.00
0.00
0.25
17.14
Total Current Assets
437.56
416.70
616.77
486.44
582.83
410.41
Net Current Assets (Including Current Investments)
277.66
215.95
438.87
344.27
458.74
317.75
Total Current Assets Excluding Current Investments
437.56
416.70
616.77
486.44
582.83
410.41
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
605.19
594.12
788.91
672.59
776.63
607.44
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
317.60
384.39
382.17
379.98
230.49
215.70
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Compare Balance Sheet Results of Travere Therapeutics, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
114.83
722.17
-607.34
-84.10%
Shareholder's Funds
114.83
722.17
-607.34
-84.10%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
317.60
50.69
266.91
526.55%
Secured Loans
317.60
50.69
266.91
526.55%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
18.73
56.61
-37.88
-66.91%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
34.24
-34.24
-100.00%
Total Non-Current Liabilities
330.46
106.56
223.90
210.12%
Current Liabilities
Trade Payables
24.80
8.68
16.12
185.71%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
34.24
-34.24
-100.00%
Total Current Liabilities
159.90
70.70
89.20
126.17%
Total Liabilities
605.19
899.42
-294.23
-32.71%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
24.70
4.87
19.83
407.19%
Less: Accumulated Depreciation
10.10
1.22
8.88
727.87%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
14.60
3.65
10.95
300.00%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0
0
0.00
0.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
39.16
1.54
37.62
2,442.86%
Total Non-Current Assets
167.63
5.19
162.44
3,129.87%
Current Assets Loans & Advances
Current Investments
229.76
662.27
-432.51
-65.31%
Inventories
5.88
0
5.88
0.00%
Sundry Debtors
80.13
0
80.13
0.00%
Cash and Bank
93.03
212.38
-119.35
-56.20%
Other Current Assets
410.11
874.65
-464.54
-53.11%
Short Term Loans and Advances
1.30
0
1.30
0.00%
Total Current Assets
437.56
894.23
-456.67
-51.07%
Net Current Assets (Including Current Investments)
277.66
823.54
-545.88
-66.28%
Total Current Assets Excluding Current Investments
437.56
894.23
-456.67
-51.07%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
605.19
899.42
-294.23
-32.71%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
317.60
50.69
266.91
526.55%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Other Long Term Liabilities
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Fixed Assets
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Investments
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Current Assets
Markets Mojo
Analysis not available as Data has been published for only 1 period